{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:39:54Z","timestamp":1783575594202,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jin Lei Pediatric Endocrinology Growth Research Fund for Young Physicians","award":["PEGRF-SD-20171006"],"award-info":[{"award-number":["PEGRF-SD-20171006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0721-9","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:57:09Z","timestamp":1522799829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency"],"prefix":"10.1186","volume":"17","author":[{"given":"Shuang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2990-1895","authenticated-orcid":false,"given":"Guimei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"721_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jff.2013.12.006","volume":"6","author":"P Scicchitano","year":"2014","unstructured":"Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, Palmiero P, Saba PS, Pedrinelli R, Ciccone MM. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11\u201332.","journal-title":"J Funct Foods"},{"key":"721_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/0026-0495(95)90117-5","volume":"44","author":"M Riedel","year":"1995","unstructured":"Riedel M, Hoeft B, Blum WF, von zur M\u00fchlen A, Brabant G. Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction. Metabolism. 1995;44:605\u201310.","journal-title":"Metabolism"},{"key":"721_CR3","first-page":"2076","volume":"82","author":"J Argente","year":"1997","unstructured":"Argente J. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab. 1997;82:2076\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1365-2265.1985.tb00187.x","volume":"23","author":"P Kopelman","year":"1985","unstructured":"Kopelman P, Noonan K, Goulton R, Forrest A. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity. Clin Endocrinol. 1985;23:87\u201394.","journal-title":"Clin Endocrinol"},{"key":"721_CR5","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1210\/jc.2009-1369","volume":"94","author":"TL Stanley","year":"2009","unstructured":"Stanley TL, Levitsky LL, Grinspoon SK, Misra M. Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab. 2009;94:4875\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR6","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1210\/jc.2008-0169","volume":"93","author":"AL Utz","year":"2008","unstructured":"Utz AL, Yamamoto A, Hemphill L, Miller KK. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J Clin Endocrinol Metab. 2008;93:2507\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR7","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1210\/jc.2009-1295","volume":"94","author":"H Makimura","year":"2009","unstructured":"Makimura H, Stanley T, Mun D, Chen C, Wei J, Connelly JM, Hemphill LC, Grinspoon SK. Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity. J Clin Endocrinol Metab. 2009;94:5131\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2006.02569.x","volume":"65","author":"JD Carmichael","year":"2006","unstructured":"Carmichael JD, Danoff A, Milani D, Roubenoff R, Lesser ML, Livote E, Reitz RE, Ferris S, Kleinberg DL. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90. Clin Endocrinol. 2006;65:169\u201377.","journal-title":"Clin Endocrinol"},{"key":"721_CR9","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1210\/jc.2008-1333","volume":"93","author":"H Makimura","year":"2008","unstructured":"Makimura H, Stanley T, Mun D, You SM, Grinspoon S. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab. 2008;93:4254\u201360.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1365-2265.2011.04195.x","volume":"76","author":"H Makimura","year":"2012","unstructured":"Makimura H, Feldpausch MN, Stanley TL, Sun N, Grinspoon SK. Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size. Clin Endocrinol. 2012;76:220\u20137.","journal-title":"Clin Endocrinol"},{"key":"721_CR11","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1210\/jc.2013-2063","volume":"98","author":"MA Bredella","year":"2013","unstructured":"Bredella MA, Gerweck AV, Lin E, Landa MG, Torriani M, Schoenfeld DA, Hemphill LC, Miller KK. Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity. J Clin Endocrinol Metab. 2013;98:3864.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR12","first-page":"727","volume":"82","author":"G Johannsson","year":"1997","unstructured":"Johannsson G, M\u00e5rin P, L\u00f6nn L, Ottosson M, Stenl\u00f6f K, Bj\u00f6rntorp P, Sj\u00f6str\u00f6m L, Bengtsson BA. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab. 1997;82:727\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.300.5.509","volume":"300","author":"J Lo","year":"2008","unstructured":"Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Hang L, Grinspoon S. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial. JAMA. 2008;300:509\u201319.","journal-title":"JAMA"},{"key":"721_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/EJE-11-1068","volume":"166","author":"MA Bredella","year":"2012","unstructured":"Bredella MA, Lin E, Brick DJ, Gerweck AV, Harrington LM, Torriani M, Thomas BJ, Schoenfeld DA, Breggia A, Rosen CJ. Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial. Eur J Endocrinol. 2012;166:601.","journal-title":"Eur J Endocrinol"},{"key":"721_CR15","first-page":"493","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years. Chin. J Pediatr. 2009;47:493\u20138.","journal-title":"J Pediatr"},{"key":"721_CR16","first-page":"487","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Chin. J Pediatr. 2009;47:487\u201392.","journal-title":"J Pediatr"},{"key":"721_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51:170\u20139.","journal-title":"Arch Dis Child"},{"key":"721_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"D Matthews","year":"1985","unstructured":"Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"721_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrendo.2013.64","volume":"9","author":"DE Berryman","year":"2013","unstructured":"Berryman DE, Glad CA, List EO, Johannsson G. The GH\/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol. 2013;9:346\u201356.","journal-title":"Nat Rev Endocrinol"},{"key":"721_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ghir.2014.12.005","volume":"25","author":"TL Stanley","year":"2015","unstructured":"Stanley TL, Grinspoon SK. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies. Growth Hormon IGF Res. 2015;25:59\u201365.","journal-title":"Growth Hormon IGF Res"},{"key":"721_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/jc.2008-1357","volume":"94","author":"KC Mekala","year":"2008","unstructured":"Mekala KC, Tritos NA. Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis. J Clin Endocrinol Metab. 2008;94:130\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR22","first-page":"E848","volume":"277","author":"CH Gravh\u00f8lt","year":"1999","unstructured":"Gravh\u00f8lt CH, Schmitz O, Simonsen L, B\u00fclow J, Christiansen JS, M\u00f8ller N. Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. Am J Physiol. 1999;277:E848.","journal-title":"Am J Physiol"},{"key":"721_CR23","first-page":"283","volume":"41","author":"A Garten","year":"2012","unstructured":"Garten A, Schuster S, Kiess W. The insulin-like growth factors in adipogenesis and obesity. Am J Physiol Endocrinol Metab. 2012;41:283\u201395.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"721_CR24","first-page":"296","volume":"13","author":"S Ed\u00e9n","year":"1993","unstructured":"Ed\u00e9n S, Wiklund O, Oscarsson J, Ros\u00e9n T, Bengtsson BA. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Endocrinol Metab Clin N Am. 1993;13:296\u2013301.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"721_CR25","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1210\/jc.2003-030840","volume":"89","author":"P Maison","year":"2004","unstructured":"Maison P, Griffin S, Nicouebeglah M, Haddad N, Balkau B, Chanson P. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab. 2004;89:2192.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR26","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2011-0273","volume":"96","author":"T Krusenstjernahafstr\u00f8m","year":"2011","unstructured":"Krusenstjernahafstr\u00f8m T, Clasen BF, M\u00f8ller N, Jessen N, Pedersen SB, Christiansen JS, J\u00f8rgensen JO. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. J Clin Endocrinol Metab. 2011;96:2548\u201357.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR27","first-page":"1412","volume":"85","author":"A Kamel","year":"2000","unstructured":"Kamel A, Norgren S, Elimam A, Danielsson P, Marcus C. Effects of growth hormone treatment in obese prepubertal boys. J Clin Endocrinol Metab. 2000;85:1412\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"721_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00535-004-1541-4","volume":"40","author":"K Nakajima","year":"2005","unstructured":"Nakajima K, Hashimoto E, Kaneda H, Tokushige K, Shiratori K, Hizuka N, Takano K. Pediatric nonalcoholic steatohepatitis associated with hypopituitarism. J Gastroenterol. 2005;40:312\u20135.","journal-title":"J Gastroenterol"},{"key":"721_CR29","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1530\/EJE-12-0002","volume":"166","author":"CJ Gardner","year":"2012","unstructured":"Gardner CJ, Irwin AJ, Daousi C, McFarlane IA, Joseph F, Bell JD, Thomas EL, Adams VL, Kemp GJ, Cuthbertson DJ. Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study. Eur J Endocrinol. 2012;166:993\u20131002.","journal-title":"Eur J Endocrinol"},{"key":"721_CR30","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1053\/j.gastro.2006.12.024","volume":"132","author":"Y Takahashi","year":"2007","unstructured":"Takahashi Y, Iida K, Takahashi K, Yoshioka S, Fukuoka H, Takeno R, Imanaka M, Nishizawa H, Takahashi M, Seo Y, et al. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Gastroenterology. 2007;132:938\u201343.","journal-title":"Gastroenterology"},{"key":"721_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/EJE-12-0252","volume":"167","author":"H Nishizawa","year":"2012","unstructured":"Nishizawa H, Iguchi G, Murawaki A, Fukuoka H, Hayashi Y, Kaji H, Yamamoto M, Suda K, Takahashi M, Seo Y, et al. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. Eur J Endocrinol. 2012;167:67\u201374.","journal-title":"Eur J Endocrinol"},{"key":"721_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1687-9856-2014-22","volume":"2014","author":"M Slattery","year":"2014","unstructured":"Slattery M, Bredella MA, Stanley T, Torriani M, Misra M. Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls. Int J Pediatr Endocrinol. 2014;2014:22.","journal-title":"Int J Pediatr Endocrinol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0721-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T19:35:40Z","timestamp":1554233740000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0721-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0721-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethic Committee of The Second Hospital of Shandong University and conducted in accordance with Helsinki\u2019s Declaration. All the patients and their parents gave their written information consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"66"}}